Stem Cells, Vol 11, 235-242, Copyright © 1993 by AlphaMed Press

ORIGINAL ARTICLES

Cell proliferation and differentiation in chemical leukemogenesis

RD Irons and WS Stillman
Molecular Toxicology and Environmental Health Sciences Program, School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262.

In tissues such as bone marrow with normally high rates of cell division, proliferation is tightly coordinated with cell differentiation. Survival, proliferation and differentiation of early hematopoietic progenitor cells depend on the growth factors, interleukin 3 (IL-3) and/or granulocyte-macrophage colony stimulating factor (GM-CSF) and their synergism with other cytokines. We provide evidence that a characteristic shared by a diverse group of compounds with demonstrated leukemogenic potential is the ability to act synergistically with GM-CSF. This results in an increase in recruitment of a resting population of hematopoietic progenitor cells normally unresponsive to the cytokine and a twofold increase in the size of the proliferating cell population normally regarded to be at risk of transformation in leukemogenesis. These findings support the possibility that transient alterations in hematopoietic progenitor cell differentiation may be an important factor in the early stages of development of leukemia secondary to chemical or drug exposure.

This article has been cited by other articles:

				U. RANGAN and R. SNYDER Scientific Update on Benzene Ann. N.Y. Acad. Sci., December 26, 1997; 837(1): 105 - 113. [Full Text] [PDF]

				B. Hazel, C Baum, and G. Kalf Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts Stem Cells, November 1, 1996; 14(6): 730 - 742. [Abstract]